Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Fertil Steril. 2020 Feb 25;113(3):552–560.e3. doi: 10.1016/j.fertnstert.2019.11.008

Table 3. Change in semen parameters from baseline to month 3.

Data are presented as median (interquartile range) or mean ± standard deviation (SD).

Parameters Antioxidants Placebo P value for comparison of change between Antioxidants and Placebo groups*
Sperm concentration (million/ml) −4.0 (−12.0, 5.7)^, n=82 2.4 (−9.0, 15.5), n=82 0.029
Normal morphology (%) 0 (−2.0, 1.0), n=55 0 (−2.0, 1.0), n=55 0.470
Total motility (%) −1.6 ± 16.0, n=82 −1.1 ± 13.7, n=82 0.822
DNA fragmentation (SCSA, DNA fragmentation index) (%) 0.8 (−3.4, 3.8), n=65 0.2 (−5.7, 6.4), n=70 0.548
Total sperm count (million) −10.6 (−32.5, 12.6)a, n=82 1.6 (−21.8, 42.9), n=82 0.021
Total motile sperm count (million) −4.0 (−13.2, 9.9), n=82 1.5 (−11.8, 15.4), n=82 0.043
*

Student’s t test or Wilcoxon’s rank-sum test was used.

^

Significant change (p<0.05) from baseline to month 3.

HHS Vulnerability Disclosure